HeartSciences Inc. (NASDAQ:HSCS) Short Interest Up 115.9% in June

HeartSciences Inc. (NASDAQ:HSCS) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totaling 123,640 shares, an increase of 115.9% from the June 15th total of 57,278 shares. Based on an average daily trading volume, of 13,681,823 shares, the days-to-cover ratio is currently 0.0 days. Currently, 4.1% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

HSCS has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of HeartSciences in a research note on Wednesday, June 24th. Ascendiant Capital Markets decreased their target price on shares of HeartSciences from $9.00 to $8.00 and set a “buy” rating on the stock in a report on Tuesday, March 24th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $8.00.

Institutional Inflows and Outflows

An institutional investor recently raised its position in HeartSciences stock. DRW Securities LLC boosted its stake in HeartSciences Inc. (NASDAQ:HSCS) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,065 shares of the company’s stock after purchasing an additional 11,455 shares during the quarter. DRW Securities LLC owned about 2.99% of HeartSciences worth $294,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 17.24% of the company’s stock.

HeartSciences Price Performance

Shares of NASDAQ HSCS opened at $2.74 on Friday. The firm has a market capitalization of $8.71 million, a P/E ratio of -0.55 and a beta of 1.78. The company has a quick ratio of 1.04, a current ratio of 1.19 and a debt-to-equity ratio of 0.16. The stock’s 50-day simple moving average is $2.20 and its two-hundred day simple moving average is $2.52. HeartSciences has a twelve month low of $1.63 and a twelve month high of $4.30.

About HeartSciences

HeartSciences, Inc (NASDAQ: HSCS) is a medical device company focused on the development and commercialization of advanced, non‐invasive cardiac diagnostic technologies. The company’s flagship product, MyoVista, is a high‐fidelity electrocardiograph (ECG) designed to detect subtle changes in cardiac function that may indicate myocardial ischemia or left ventricular dysfunction. By leveraging high‐frequency wavelet analysis within the QRS complex, MyoVista provides clinicians with enhanced visualization and analytical capabilities that extend beyond those of standard ECG systems.

HeartSciences supports the MyoVista system with an integrated software suite that automates data analysis and report generation, facilitating seamless integration into existing clinical workflows.